Last year, a team of McMaster researchers made headlines with their invention which allows vaccines to be stored safely and affordably for weeks at a time at temperatures up to 40C.

Now, Carlos Filipe, co-author of the research paper is part of a five-person startup company called Elarex Inc. bringing this technology to market, opening the doors for life-saving anti-viral vaccines to reach remote and impoverished parts of the world. He is also the chair of Chemical Engineering at McMaster University.

Research Engineer Sahar Esmaeili Samani also shares her journey from graduate student to starting her work with Elarex in March 2020, right when the pandemic hit. 

Interviewed by: John Preston

Produced by: Jessie Park

Edited by: Jin Lee and Dan Kim

Follow us on Twitter and Instagram @mcmastereng. Read more at www.eng.mcmaster.ca/news.